Mouse Sequencing Consortium (MSC)

Download Profile PDF
At a Glance
  • Status: Completed Consortium
  • Year Launched: 2000
  • Initiating Organization: National Human Genome Research Institute, NIH
  • Initiator Type: Government
  • No disease focus
  • Location: International

Abstract

Consortium History

October 2000: Consortium launched

Financing

Members of the Mouse Sequencing Consortium (MSC) and their contributions to the effort are SmithKline Beecham ($6.5 million), the Merck Genome Research Institute ($6.5 million), Affymetrix, Inc. ($3.5 million), the Wellcome Trust ($7.75 million), and six of the National Institutes ($34 million), including the National Cancer Institute, National Human Genome Research Institute, National Institute on Deafness and Other Communication Disorders, National Institute of Diabetes and Digestive and Kidney Disease, National Institute of Neurological Disorders and Stroke, and National Institute of Mental Health (NIMH).

Points of Contact

Mary Prescott
phone: 312 397-6604

Sponsors & Partners

Affymetrix, Inc.

Merck Genome Research Institute

National Cancer Institute (NCI)

National Human Genome Research Institute (NHGRI)

National Institute of Diabetes and Digestive and Kidney Disease (NIDDK)

National Institute of Mental Health (NIMH)

National Institute of Neurological Disorders and Stroke (NINDS)

National Institute on Deafness and Other Communication Disorders (NIDCD)

SmithKline Beecham

The Wellcome Trust

Last Updated: 04/21/2016
The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.
Register your consortium  
All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.